CF1

10.0%

2.2¢ complii fintech solutions ltd

Ann: Market Update, page-228

First 228 Last

Share
Profile

Follow
jscopas

1,215 Posts.

56

04/05/17

14:00

Post #: 24471669
Share

Originally posted by meerkat ↑

For what it's worth I regard this morning's disclosure as highly misleading. But each to their own. I have never previously seen a company report a failure without at the same time presenting mitigating factors to offset the bad news. It would have taken nothing to mention that the Sentry pilot program was still on track - absolutely nothing - and it would have offset the sp slide which anyone with half a brain would know was to follow by just reporting bad news alone.
At the very least IMO it shows IAM's disregard of shareholders whose interests it is obliged to protect.
Anyway, I've walked away from this non-performing company who apparently intend to conduct their business by not informing the market about the identity of their clients - keeping the market and shareholders in the dark just like this morning's announcement exemplifies is not the sort of company I want anything to do with.
If the Sentry is off - and we only have IAM's word that it was their decision to drop the deal - but it takes two to tango, and if as some say they are happy that IAM stood their ground, they are forgetting that the other party also stood their ground and decided it wasn't in their interests to proceed either. Customers are the most important asset of any company, not the product, not the management, but customers - and it is already obvious IAM is struggling in that department.
If Sentry have walked then IAM will at some point be forced to disclose that whether they like it or not.
If by some miracle IAM succeed in their program there's plenty of time to get on board for those with a taste for this kind of speculative company. Revenues are pathetic for a company with IAM's market cap and that won't go unnoticed by more astute investors than those who populate HC threads.
That's my last post on IAM for while....

Expand

I have to respectively disagree with you .the product is the most important it's what brings customers .

IAM Price at posting: 3.7¢ Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BUX

Buxton projects new graphite province discovery at WA Narryer play

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

There are more pages in this discussion • 116 more messages in this thread...

First 228 Last

Add CF1 (ASX) to my watchlist

(20min delay)
Last 2.2¢		Change 0.002(10.0%)		Mkt cap ! $12.58M

Open	High	Low	Value	Volume
2.1¢	2.2¢	2.1¢	$7.78K	360.6K

Buyers (Bids)

No.	Vol.	Price($)
1	103090	2.2¢

Sellers (Offers)

Price($)	Vol.	No.
2.3¢	300000	1

View Market Depth

No.	Vol.	Price($)
1	103090	0.022
1	491617	0.020
1	200000	0.019
3	1434231	0.018
1	1000000	0.017

Price($)	Vol.	No.
0.023	300000	1
0.024	125000	1
0.026	64744	1
0.028	483161	1
0.030	827135	4

Last trade - 15.54pm 04/10/2024 (20 minute delay)

CF1 (ASX) Chart

Ann: Market Update, page-228

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BCI reaches close of funding facility for salt-first part of Mardie project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Buxton projects new graphite province discovery at WA Narryer play

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Market Update, page-228

Top Stories

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BCI reaches close of funding facility for salt-first part of Mardie project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Buxton projects new graphite province discovery at WA Narryer play

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News